万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/14401843
3、投稿网址：http://mc.manuscriptcentral.com/res
4、官网邮箱：respirology@resphealth.uwa.edu.au
5、官网电话：+61 8 6151 0807
6、期刊刊期：月刊，一年出版12期。
2021年5月25日星期二
投稿须知【官网信息】
Respirology
AUTHOR GUIDELINES
1. SUBMISSION
Authors should kindly note that submission implies (i) that the content has not been published previously, in any language, in whole or in part, except as a brief abstract in the proceedings of a scientific meeting or symposium; and (ii) that the manuscript is not currently under consideration for publication elsewhere.
Please read the complete Author Guidelines carefully prior to submission, including the sections on publication fees.
SUBMISSION REQUIREMENTS
Please use the manuscript preparation checklist before submitting your manuscript. Manuscripts should then be submitted online at http://mc.manuscriptcentral.com/res
• Respirology requires the corresponding author to be registered with their ORCID iD and linked email address. ORCID (Open Researcher and Contributor ID) is a service that uniquely identifies authors' and researchers' contributions to the scholarly literature (for more information, visit http://orcid.org/). An ORCID-identifier will avoid any confusion and ensure appropriate use of your name and contact details.
If the corresponding author has an existing Respirology account but not an ORCID iD, the required ORCID identifier can be obtained by logging into your ScholarOne user account (then go to "Edit Account"). For more information click here.
If the corresponding author is registered at ORCID, but the contact email address in Scholar One is not the ORCID-linked email address, the corresponding author will need to change the ‘Primary Email Address’ for the Respirology account accordingly and list the alternative email address as either the ‘Primary CC Email Address’ or the ‘Secondary Email Address’. This will help prevent a duplicate user account being created.
Respirology also strongly encourages all co-authors to be registered at ORCID and use the ORCID iD and linked email address in Scholar One. The corresponding author is strongly advised to use the ORCID iD linked email addresses of all co-authors when registering co-authors during manuscript submission.
• A cover letter containing an authorship statement should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file. The cover letter must include the following sections: (1) introductory sentence with manuscript title and author names, (2) paragraph outlining (in less than five sentences) why the work described in the manuscript is important, novel and suitable for publication in Respirology, and (3) a final paragraph outlining any special notes related to word count, ethics approval, patient consent, conflict of interest, relationship with recent research submitted elsewhere for publication and copyright.
• Every author on the manuscript has provided the corresponding author with a completed copy of the ICMJE Disclosure Form . The corresponding author has summarized the disclosure information provided by each authors in a Disclosure of Competing Interests - Summary Statement on the manuscript.
• One Word file needs to be submitted, including: The title page and all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.
• Manuscripts are to be typed double-spaced (including references, tables, figure legends and footnotes), in 12-point type, on A4 size paper with 3-cm margins at the top and the left-hand side of the pages and must be in Word (doc or docx) format only (pdf cannot be accepted and will be returned to the author for conversion). All pages should be numbered consecutively beginning with the title page.
• Each figure should be supplied as a separate file, with the figure number incorporated in the file name.
COVID-19: The COVID-19 pandemic may affect the ability of editors and reviewers to attend to manuscripts. We ask for your patience while manuscript processing and peer review may take longer than usual.
Important information for Authors of COVID-19 manuscripts:
Fast-tracking of COVID-19 submissions is not guaranteed and will be (i) at the discretion of the Editors in Chief based on interest, and (ii) subject to peer review turnaround times. Respirology remains committed to a thorough peer review process to ensure the integrity of all its publications.
COVID-19 studies that are retrospective or have small numbers will not be considered. Manuscripts are unlikely to be considered if they report routine clinical and laboratory observations of COVID cases, without innovative findings or adequate consideration of confounding factors.
2. AIMS AND SCOPE
Respirology is the official journal of the Asian Pacific Society of Respirology. It is the preferred English language journal of the Japanese Respiratory Society, the Thoracic Society of Australia and New Zealand and the Taiwanese Society of Pulmonary and Critical Care Medicine, and an official journal of the World Association of Bronchology and Interventional Pulmonology. The journal publishes peer-reviewed articles of scientific excellence in clinical and clinically-relevant experimental respiratory biology and disease. Manuscripts reporting research and clinical trials within the fields of allied health; cell and molecular biology; epidemiology; immunology; pathology; pharmacology; physiology; intensive and critical care; paediatric respiratory medicine; interventional pulmonology and thoracic surgery are welcomed.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Original Articles
Respirology encourages the submission of manuscripts focusing on clinical or laboratory research in areas relevant to the practice of respiratory medicine. Original articles must not be longer than 2500 words excluding the summary at a glance (maximum 50 words), abstract (maximum 250 words, structured), references (maximum 50), tables and figure legends. The combined number of figures and/or tables must not exceed 6. Unless justified in the cover letter, manuscripts exceeding the word count or the maximum number of references, tables or figures may be returned to the authors for reduction before being considered for peer review. Please find the Journal’s template here.
Editorials, Commentaries and Reviews
Editorials, commentaries and reviews are generally commissioned by the Editors-in-Chief. Author guidelines, including word counts, for editorials, commentaries and reviews will be provided by the Editorial Office at the time of invitation.
Suggestions for reviews and commentaries should be submitted online as a ‘manuscript proposal’ via ScholarOne (https://mc.manuscriptcentral.com/res). Propositions via email will be declined immediately. If accepted for publication, unsolicited reviews and commentaries attract the regular publication fee.
Respirology offers authors of review articles the opportunity to submit a case report to the Open Access journal Respirology Case Reports at the same time as submitting their review article to Respirology. The complementary case report should describe a clinical case which translates the content of the review article. If accepted, the case report and review article will be published simultaneously in the respective journals and electronically linked. The case report should comply with the Author Guidelines of Respirology Case Reports and is subject to the article publication charges of Respirology Case Reports.
Systematic Reviews
Systematic reviews may or may not use statistical methods (meta-analysis) to analyze and summarize the results of the included studies.
Respirology strongly encourages the registration of systematic reviews on PROSPERO, the international prospective register of systematic reviews. Details on when, why and how to register are available at PROSPERO. Registration on PROSPERO will be required from 1 January 2022 onwards.
Respirology has endorsed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement, as described in the PRISMA Explanatory and Elaboration document. It recommends the use of its checklist and flow diagram as a guide to a systematic review with or without a meta-analysis approach (www.prisma-statement.org). Respirology requires authors to include a similar flow chart as part of the manuscript. At submission, the authors must also upload a completed copy of the checklist to indicate which items have been implemented in the manuscript.
Authors of meta-analyses of observational studies must follow the Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guidelines and checklist, and include as part of their submission a copy of the completed checklist (Table 1) indicating the items that have been implemented.
Systematic reviews are limited to 3500 words –excluding the abstract (maximum 250 words, unstructured), references (maximum 50), tables and figures (maximum 6 combined). Please find the journal's template here.
If accepted for publication, systematic reviews attract the regular publication fee.
Correspondences
Correspondences are letters regarding articles published in Respirology. Correspondences must be fewer than 500 words and may include maximum 4 references and 1 table or figure. An abstract is not required. Author(s) of the article commented on may be invited to respond. Respirology reserves the right to accept or reject letters for publication, and may amend or extract text without misrepresenting the writer’s views. Please find the Journal’s template here.
Unsolicited correspondences that do not relate to articles published in Respirology, should be submitted online as ‘manuscript proposal’ at https://mc.manuscriptcentral.com/res. Proposals via email will be declined immediately. The publication fee applies for Correspondences that are not related to a published Respirology article.
An invitation to correspond by way of a Scientific Letter is at the discretion of the Editor in Chief and unsolicited submissions cannot be considered. Scientific Letters to the Editor are reserved for preliminary reports not exceeding 1,200 words, 10 references and 1 table or figure, and do not contain an abstract. The publication fee applies for Scientific Letters.
Clinical Practice Guidelines and Position Statements
Respirology welcomes the submission of Clinical Practice Guidelines and Position Statements developed on behalf of any respiratory society. Clinical Practice Guidelines and Position Statements are subject to peer review. Respirology cannot consider any Clinical Practice Guidelines and Position Statements that have been published previously in full or in part, online or in print.
Societies interested in publishing a Clinical Practice Guidelines or Position Paper in Respirology should seek approval to submit from the Editor in Chief via the Editorial Office (respirology@resphealth.uwa.edu.au). Following approval, the Editorial Office will provide the authors with the information required to prepare and submit Clinical Practice Guidelines and Position Statements to the Journal.
Case Reports
Respirology no longer accepts the submission of case reports. Instead, case reports can be submitted to Respirology Case Reports, the official Open Access case reports journal of the Asian Pacific Society of Respirology: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2051-3380
4. PREPARING THE SUBMISSION
English Expression and Manuscript Style
All contributions should be written in English (conforming to the Concise Oxford English Dictionary) and should be concise. The Editors reserve the right to return manuscripts to the author for shortening or English language editing at any point during the peer review process. For advice on reducing manuscript word count, Respirology recommends this Wiley exchange blog post. In some cases, Respirology may only consider the manuscript after it has been professionally edited at the author's expense. Visit http://wileyeditingservices.com to learn about the options. In addition, the Editors and Publisher reserve the right to modify typescripts and reduce the word count of accepted manuscripts to eliminate ambiguity and repetition and to improve communication between author and reader. In following this practice the scientific content and message will not be changed. Manuscripts modified by Respirology will be returned to the authors for approval before publication.
Respirology no longer accepts the use of the eponyms ‘Clara cell’, ‘Clara cell secretory protein’ and ‘Wegener’s granulomatosis’ and will replace these terms with ‘club cell’, ‘club cell secretory protein’ and ‘granulomatosis with polyangiitis’ respectively. The old eponyms will be used in parentheses until the end of 2014. Further background information about this change in terminology can be found in the following publications:
*Winkelmann A, Noack T. The Clara cell: a “Third Reich eponym”? Eur Resp J. 2010;36: 722-7.
*Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts R. Granulomatosis with polyangiitis (Wegener’s): an alternative name for Wegener's granulomatosis. Ann Rheum Dis. 2011;70: 704.
Abbreviations
The use of abbreviations is discouraged except for standard abbreviations of units of measure. Abbreviations used must be defined in parentheses on first mention in the abstract and again in the body of the manuscript. If applicable, they must be re-defined in the figure legend or table caption. A list of used abbreviations including their definitions must be provided as part of the manuscript.
Statistical Methods and Hypothesis
Where appropriate, all original articles should state the hypothesis that is being tested and detail the statistical method that was used.
For advice on statistical reporting, Respirology encourages authors to refer to the SAMPL guidelines: Lang T, Altman D. Basic statistical reporting for articles published in clinical medical journals: the SAMPL guidelines. In: Smart P, Maisonneuve H, Polderman A (eds.) Science Editors' Handbook, European Association of Science Editors, 2013.
For guidance on reporting of results in causal inference studies, we encourage authors to refer to the following Respirology Editorial: Hancox, RJ. When is a confounder not a confounder? https://doi.org/10.1111/resp.13460
Respirology uses the services of biostatisticians for the assessment of statistical methodology of selected manuscripts.
Parts of the Manuscript
Manuscripts should contain, in this order, a title page, summary at a glance (original articles only), abstract (see requirements below for each article type), key words, short title, text of the manuscript, data sharing statement (required for clinical trial studies, encouraged for other studies), acknowledgements, references, tables, and figure legends. Please note that in addition to including this in the manuscript, the title, abstract, names of the authors and their affiliations, short title and key words will have to be entered upon submission of the manuscript in ScholarOne Manuscripts.
Title Page
The title page should include:
the title
all authors' full names and affiliations - please read the Authorship section for important information on authorship.
contact address and email for the corresponding author
word count for the abstract and text (without references, tables or figure legends)
Title
Choose an informative title, which accurately describes the research study and targets the preferred audience by the authors. We recommend that one or two key words are used in the title. An effective title is a concise and captivating summary statement of your study, which contributes to the detection of the published manuscript in an online search on the topic.
Key Words
Key words help to make your research publication more discoverable in online searches. Include up to 7 key words in the manuscript keeping the following recommendations in mind:
Consider key words that are broadly recognized and serve as predictable search item terms in online search engines, for example Google ScholarTM
Use the Medical Subject Headings (MeSH) list provided by the US National Library of Medicine as a general guide to prevalent topic names in your field of specialization.
Consider using phrases rather than single words to specify a topic (e.g. severe asthma diagnosis). Each word of the phrase will contribute individually and in combination to discoverability.
Include a synonym if more than one version of a key word is commonly used (for example COVID-19 and coronavirus disease).
Check that the key words are consistently phrased and repeated several times in the title, abstract, summary at a glance and manuscript content (for example in section headings).
Test your selected key words online by putting yourself in the shoes of your target audience and check if your study can be discovered by your preferred viewers.
Download our Infographic on Key Word selection here.
For more information, see Wiley Author Resources.
Summary at a Glance
For Original Articles only, authors should provide a ‘Summary at a Glance’ paragraph of less than 50 words highlighting what is new, what is tested, what the presented study adds to the literature and/or what clinical impact the research outcomes have. We recommend that the authors use their selected key words where appropriate in this section.
Abstract
Original Articles: Concise abstract of no more than 250 words which is structured as follows: Background and objective, Methods, Results and Conclusion. The abstract should not contain references or footnotes. We recommend that the authors use their selected key words where appropriate in this section.
Reviews: An unstructured and concise abstract of no more than 250 words should be included. The abstract should not contain references or footnotes. We recommend that the authors use their selected key words where appropriate in this section.
Editorials and Correspondences: No abstract is required, please type N/A in the abstract box upon submission in ScholarOne Manuscripts.
Short Title
A short title of fewer than 40 characters (including spaces) must be provided. We recommend authors to include one or two a key words in the short title.
Text
Original Articles should be arranged under the usual headings of Introduction, Methods, Results and Discussion.
Methods (including statistical methods used, study design, participant recruitment and sample collection) should be described in sufficient detail to make clear how the results were derived. The location (city, state, country) of manufacturers specified in the text should be provided. Generic names of drugs should be used. SI units should be used throughout, with few exceptions, e.g. blood pressure (mmHg). If monetary values are mentioned in the manuscript, the equivalence in US dollars should also be presented. When applicable, statements regarding Ethics Committee and Institutional Review Board approval, written informed consent and clinical trial registration must be included in this section. Respirology recommends the use of EthicsGen as a free tool to formulate an appropriate and comprehensive ethics statement for animal and human research studies - the ethics statement generator is available to use in English and Simplified Chinese language, with final ethics statements generated in English. Authors are encouraged to submit descriptions of non-critical or previously published methods as online supporting information.
Data Sharing, Data Availability Statement, Data Citation
Respirology encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository before publication. Authors are also encouraged to provide a data availability statement, including a link to the repository they have used, to publish alongside their paper.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/14401843/homepage/forauthors.html
